Toshiaki Monkawa

Toshiaki Monkawa

Auto-generated profile, based on publicly available information

Toshiaki Monkawa

Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1996 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
FYFumio Yoshikawa
Fumio Yoshikawa
MMMitsuhiro Morita
Mitsuhiro Morita
TMToshiaki Monkawa
Toshiaki Monkawa
TMTakayuki Michikawa
Takayuki Michikawa
TFTeiichi Furuichi
Teiichi Furuichi
KMKatsuhiko Mikoshiba
Katsuhiko Mikoshiba
To define the structural determinants for inositol 1,4,5-trisphosphate (IP3) binding of the type 1 inositol 1,4,5-trisphosphate receptor (IP3R1), we developed a means of expressing the N-terminal 734 amino acids of IP3R1 (T734), which contain the IP3 binding region, in Escherichia coli. The T734 protein expressed in E. coli exhibited a similar binding specificity and affinity for IP3 as the native IP3R from mouse cerebellum. Deletion mutagenesis, in which T734 was serially deleted from the N terminus up to residue 215, markedly reduced IP3 binding activity. However, when deleted a little more toward the C terminus (to residues 220, 223, and 225), the binding activity was retrieved. Further N-terminal deletions over the first 228 amino acids completely abolished it again. C-terminal deletions up to residue 579 did not affect the binding activity, whereas those up to residue 568 completely abolished it. In addition, the expressed 356-amino acid polypeptide (residues 224-579) exhibited specific binding activity. Taken together, residues 226-578 were sufficient and close enough to the minimum region for the specific IP3 binding, and thus formed an IP3 binding “core.” Site-directed mutagenesis was performed on 41 basic Arg and Lys residues within the N-terminal 650 amino acids of T734. We showed that single amino acid substitutions for 10 residues, which were widely distributed within the binding core and conserved among all members of the IP3R family, significantly reduced the binding activity. Among them, three (Arg-265, Lys-508, and Arg-511) were critical for the specific binding, and Arg-568 was implicated in the binding specificity for various inositol phosphates. We suggest that some of these 10 residues form a basic pocket that interacts with the negatively charged phosphate groups of IP3.

1 June 1995 in Journal of Biological Chemistry
Verified
Journal Article
Open access
TMToshiaki Monkawa
Toshiaki Monkawa
AMAtsushi Miyawaki
Atsushi Miyawaki
TSTomoyasu Sugiyama
Tomoyasu Sugiyama
HYHiroyuki Yoneshima
Hiroyuki Yoneshima
MYMiki Yamamoto-Hino
Miki Yamamoto-Hino
KMKatsuhiko Mikoshiba
Katsuhiko Mikoshiba
The inositol 1,4,5-trisphosphate receptor (IP3R) exists as a tetrameric complex to form a functional inositol 1,4,5-trisphosphate-gated Ca2+ channel. Molecular cloning studies have shown that there are at least three types of IP3R subunits, designated type 1, type 2, and type 3. The levels of expression of IP3R subunits in various cell lines were investigated by Western blot analysis using type-specific antibodies against 15 C-terminal amino acids of each IP3R subunit. We found that all the three types of IP3R subunits were expressed in each cell line examined, but their levels of expression varied. To determine whether IP3Rs form heterotetramers, we employed immunoprecipitation experiments using Chinese hamster ovary cells (CHO-K1 cells), in which all three types are abundantly expressed. Each type-specific antibody immunoprecipitated not only the respective cognate type but also the other two types. This result suggests that distinct types of IP3R subunits assemble to form heterotetramers in CHO-K1 cells. We also detected heterotetramers in rat liver, in which IP3R type 1 and type 2 are expressed abundantly. Previous studies have shown some functional differences among IP3R types, suggesting the possibility that various compositions of subunits show distinct channel properties. The diversity of IP3R channels may be further increased by the co-assembly of different IP3R subunits to form homo- or heterotetramers.

1 March 1994 in Neuron
Verified
Journal Article
Closed access
MKMasanobu Kawasaki
Masanobu Kawasaki
SUShinichi Uchida
Shinichi Uchida
TMToshiaki Monkawa
Toshiaki Monkawa
AMAtsushi Miyawaki
Atsushi Miyawaki
KMKatsuhiko Mikoshiba
Katsuhiko Mikoshiba
SSSei Sasaki
Sei Sasaki

1 November 1994 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MHM Hayashi
M Hayashi
SSS Sasaki
S Sasaki
HTH Tsuganezawa
H Tsuganezawa
TMT Monkawa
T Monkawa
WKW Kitajima
W Kitajima
TST Saruta
T Saruta
To examine whether expression and distribution of aquaporin of collecting duct (AQP-CD) are regulated by vasopressin V2 receptor (V2R), we performed immunohistochemical studies with specific antibody against AQP-CD. Normal Wistar rats were divided into four groups and treated for 3 d; control, dehydration, vasopressin V1 receptor (V1R) antagonist (OPC-21268 120 mg/kg), V2R antagonist (OPC-31260 30 mg/kg). At time of death, urine osmolality (Uosm) in the dehydration group (1884 +/- 245 mOsm/kg) was significantly higher than that in the control (938 +/- 91). In the V2R antagonist group, Uosm was significantly decreased to 249 +/- 29, whereas V1R antagonist showed no effect on Uosm. In the control and V1R antagonist groups, immunofluorescence studies showed the AQP-CD staining of both apical membrane and subapical cytoplasm of CD cells of the cortex and the inner medulla. Dehydration increased the immunostaining of both apical membrane and subapical cytoplasm of CD cells of the inner medulla, and the degree of increase was dominant in apical membrane. In the V2R antagonist group, only faint staining of apical membrane and weak labeling of cytoplasm of CD cells of the inner medulla were observed. These changes in the localization and protein amount of AQP-CD by dehydration and V2R antagonist were quantitatively confirmed by immunogold studies and immunoblot analysis of the inner medulla. The present results indicate that the distribution and amount of AQP-CD in the CD cells are regulated by vasopressin V2 receptor.

1 October 1997 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
TMToshiaki Monkawaa
Toshiaki Monkawaa
TYTadashi Yoshidaa
Tadashi Yoshidaa
SWShu Wakinoa
Shu Wakinoa
TSToshimasa Shinkib
Toshimasa Shinkib
HAHideharu Anazawac
Hideharu Anazawac
TSTakao Sarutaa
Takao Sarutaa

1 February 2010 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
HKHideaki Kanazawa
Hideaki Kanazawa
MIMasaki Ieda
Masaki Ieda
KKKensuke Kimura
Kensuke Kimura
TATakahide Arai
Takahide Arai
HKHaruko Kawaguchi-Manabe
Haruko Kawaguchi-Manabe
KFKeiichi Fukuda
Keiichi Fukuda
Although several cytokines and neurotrophic factors induce sympathetic neurons to transdifferentiate into cholinergic neurons in vitro, the physiological and pathophysiological roles of this remain unknown. During congestive heart failure (CHF), sympathetic neural tone is upregulated, but there is a paradoxical reduction in norepinephrine synthesis and reuptake in the cardiac sympathetic nervous system (SNS). Here we examined whether cholinergic transdifferentiation can occur in the cardiac SNS in rodent models of CHF and investigated the underlying molecular mechanism(s) using genetically modified mice. We used Dahl salt-sensitive rats to model CHF and found that, upon CHF induction, the cardiac SNS clearly acquired cholinergic characteristics. Of the various cholinergic differentiation factors, leukemia inhibitory factor (LIF) and cardiotrophin-1 were strongly upregulated in the ventricles of rats with CHF. Further, LIF and cardiotrophin-1 secreted from cultured failing rat cardiomyocytes induced cholinergic transdifferentiation in cultured sympathetic neurons, and this process was reversed by siRNAs targeting Lif and cardiotrophin-1. Consistent with the data in rats, heart-specific overexpression of LIF in mice caused cholinergic transdifferentiation in the cardiac SNS. Further, SNS-specific targeting of the gene encoding the gp130 subunit of the receptor for LIF and cardiotrophin-1 in mice prevented CHF-induced cholinergic transdifferentiation. Cholinergic transdifferentiation was also observed in the cardiac SNS of autopsied patients with CHF. Thus, CHF causes target-dependent cholinergic transdifferentiation of the cardiac SNS via gp130-signaling cytokines secreted from the failing myocardium.